PARP-1 inhibitor alleviates liver lipid accumulation of atherosclerosis <i>via</i> modulating bile acid metabolism and gut microbes

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

PARP-1 inhibitor alleviates liver lipid accumulation of atherosclerosis via modulating bile acid metabolism and gut microbes

Abstract: Background Poly (ADP-ribose) polymerase 1 (PARP1) is crucial for lipid and glucose metabolism. However, no evidence was presented to investigate the relationship between liver lipid accumulation and the PARP1 inhibitor,...

Cited by 2 publications

References 43 publications

Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway

Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway

Exploring the Role of Gut Microbiota in Metabolic Diseases Based on the Gut-Liver Axis

Contact Info

Product

Resources

About